PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
13-Mar-2024 Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX Rousselot
13-Mar-2024 MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts MetrioPharm
12-Mar-2024 PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST AstraZeneca and MSD
12-Mar-2024 Vaccine monitoring crucial as SARS-CoV-2 variants continue to evolve The Francis Crick Institute
11-Mar-2024 OncoZenge Explores Strategic Options for BupiZenge™ in China OncoZenge
11-Mar-2024 Metafora Biosystems secures reimbursement in France for first IVD to help diagnose Glut1 deficiency syndrome Andrew Lloyd Associates
11-Mar-2024 Aptamer Group progresses partnership with Unilever plc Aptamer Group
08-Mar-2024 Roche presents positive topline CGM accuracy data at the 17th International Conference on Advanced Technologies and Treatments for Diabetes Roche
08-Mar-2024 AlzeCure presents new preclinical data with NeuroRestore ACD856 at leading Alzheimer's conference AlzeCure Pharma AB (publ)
08-Mar-2024 BioInnovation Institute provides EUR 7.8M in financial support as six promising companies enter its Venture House program BioInnovation Institute (BII)
08-Mar-2024 MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts MitoRx Therapeutics
08-Mar-2024 Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024 Oxford BioTherapeutics
08-Mar-2024 ramarketing announces strategic leadership appointments to support global growth ramarketing
08-Mar-2024 WELLCOME APPOINTS MHP GROUP MHP Group Limited
08-Mar-2024 BioInnovation Institute provides EUR 7.8M in financial support as six promising companies enter its Venture House program BioInnovation Institute (BII)
08-Mar-2024 Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team Accumulus Synergy, Inc.
08-Mar-2024 US FDA grants Orphan Drug Designation for iOnctura’s first-in-class autotaxin cancer therapy iOnctura
07-Mar-2024 RDS SECURES CE MARK FOR MULTISENSE® REMOTE PATIENT MONITORING SOLUTION RDS
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 Zenas BioPharma Appoints Patricia Allen to its Board of Directors Zenas BioPharma